Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update

NEXT STORY
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
PREV STORY
Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

YMCA of Northern Alberta launches Month of Giving– and needs your help in raising $100,000 for your community

author_avatar
NASDAQ Market News

Prelude Therapeutics Announces Pricing of Upsized Public Offering

author_avatar
NASDAQ Market News

Alder BioPharmaceuticals® New Data Demonstrated Eptinezumab Increased Migraine-Free Intervals (Up to 32.5 days) and Improved Quality-of-Life Outcomes in Patients with Episodic Migraine

author_avatar
NASDAQ Market News